Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Panel Supports Sapien But Urges Cautious Rollout

This article was originally published in The Gray Sheet

Executive Summary

Edwards Lifesciences’ Sapien transcatheter aortic valve met widespread expectations last week by gaining support for FDA approval from an agency advisory panel, but the experts urged FDA and Edwards to proceed cautiously.
Advertisement

Related Content

Research In Brief
Edwards Wins Approval For Sapien Just In Time For TCT
CMS Jumps Out Ahead Of FDA With Transcatheter Valve Coverage Analysis
CMS Jumps Out Ahead Of FDA With Transcatheter Valve Coverage Analysis
News In Brief
Sapien Valve Reimbursement Begins Taking Shape, But Key Questions Remain
Reimbursement News In Brief
Sapien Stroke Discussion Continues With Expanded PARTNER Analysis
Edwards' Sapien Valve: Big Survival Boost In Those Too Sick For Surgery
Edwards' Sapien Valve: Big Survival Boost In Those Too Sick For Surgery

Topics

Advertisement
UsernamePublicRestriction

Register

MT030374

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel